Vault-13

ASPIRE BIOPHARMA HLDGS INC

COM · CUSIP 738920206

0 institutional holders -13 vs Q1 2026
—reported value*
0 new 0 added 0 reduced 13 sold out net sold ≈ $363.5k (-353.3k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

051015Q1 26: 13Q2 26: 00Q1 26Q2 26
Numbers
QuarterHolders
Q1 202613
Q2 20260

Biggest buyers

None

Biggest sellers

UBS Group AG Sold out -191,499-191.5k
MORGAN STANLEY Sold out -76,955-77.0k
GEODE CAPITAL MANAGEMENT, LLC Sold out -43,384-43.4k
Crewe Advisors LLC Sold out -20,335-20.3k
VANGUARD CAPITAL MANAGEMENT LLC Sold out -7,859-7.9k
TORONTO DOMINION BANK Sold out -5,000-5.0k
VANGUARD FIDUCIARY TRUST CO Sold out -2,856-2.9k
Tower Research Capital LLC (TRC) Sold out -2,174-2.2k
CITIGROUP INC Sold out -1,846-1.8k
Avion Wealth Sold out -1,352-1.4k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
HIGHBRIDGE CAPITAL MANAGEMENT LLC 13G · institution new · filed 2026-05-15 5.2% new 273.0k 2026-05-15

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change